Annual Current Assets
$8.40 M
-$3.89 M-31.64%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total current assets is $8.40 million, with the most recent change of -$3.89 million (-31.64%) on April 30, 2024.
- During the last 3 years, IPA annual current assets has fallen by -$31.39 million (-78.88%).
- IPA annual current assets is now -78.88% below its all-time high of $39.80 million, reached on April 30, 2021.
Performance
IPA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$8.99 M
+$1.03 M+12.99%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total current assets is $8.99 million, with the most recent change of +$1.03 million (+12.99%) on October 31, 2024.
- Over the past year, IPA quarterly current assets has increased by +$1.03 million (+12.99%).
- IPA quarterly current assets is now -77.41% below its all-time high of $39.80 million, reached on April 30, 2021.
Performance
IPA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
IPA Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.6% | +13.0% |
| 3 y3 years | -78.9% | +13.0% |
| 5 y5 years | +32.2% | +13.0% |
IPA Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.9% | at low | -71.7% | +13.0% |
| 5 y | 5-year | -78.9% | +52.8% | -77.4% | +63.4% |
| alltime | all time | -78.9% | >+9999.0% | -77.4% | >+9999.0% |
ImmunoPrecise Antibodies Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $8.99 M(+13.0%) |
| Jul 2024 | - | $7.96 M(-5.3%) |
| Apr 2024 | $35.49 M(-20.6%) | $8.40 M(-25.2%) |
| Jan 2024 | - | $11.23 M(+0.8%) |
| Oct 2023 | - | $11.14 M(-6.1%) |
| Jul 2023 | - | $11.86 M(-3.5%) |
| Apr 2023 | $44.68 M(+2.9%) | $12.29 M(-12.8%) |
| Jan 2023 | - | $14.10 M(-15.4%) |
| Oct 2022 | - | $16.67 M(-20.2%) |
| Jul 2022 | - | $20.89 M(-27.8%) |
| Apr 2022 | $43.41 M(+194.4%) | $28.95 M(-8.9%) |
| Jan 2022 | - | $31.78 M(-10.4%) |
| Oct 2021 | - | $35.46 M(-5.5%) |
| Jul 2021 | - | $37.53 M(-5.7%) |
| Apr 2021 | $14.74 M(+5.5%) | $39.80 M(+107.8%) |
| Jan 2021 | - | $19.16 M(+6.3%) |
| Oct 2020 | - | $18.01 M(+85.9%) |
| Jul 2020 | - | $9.69 M(+76.1%) |
| Apr 2020 | $13.98 M(-5.5%) | $5.50 M(-4.3%) |
| Jan 2020 | - | $5.75 M(-3.2%) |
| Oct 2019 | - | $5.94 M(-12.0%) |
| Jul 2019 | - | $6.74 M(+6.1%) |
| Apr 2019 | $14.79 M(-4.0%) | $6.36 M(-13.1%) |
| Jan 2019 | - | $7.32 M(-19.4%) |
| Oct 2018 | - | $9.08 M(+155.9%) |
| Jul 2018 | - | $3.55 M(-4.7%) |
| Apr 2018 | $15.41 M(+3159.2%) | $3.72 M(+27.2%) |
| Jan 2018 | - | $2.93 M(-3.4%) |
| Oct 2017 | - | $3.03 M(+70.4%) |
| Jul 2017 | - | $1.78 M(-26.2%) |
| Apr 2017 | $472.80 K(>+9900.0%) | $2.41 M(-20.9%) |
| Jan 2017 | - | $3.04 M(+671.5%) |
| Sep 2016 | - | $394.70 K(+2292.1%) |
| Jun 2016 | - | $16.50 K(-9.8%) |
| Mar 2016 | - | $18.30 K(+92.6%) |
| Dec 2015 | $1600.00(-38.5%) | - |
| Dec 2015 | - | $9500.00(-26.4%) |
| Sep 2015 | - | $12.90 K(-43.9%) |
| Jun 2015 | - | $23.00 K(-30.7%) |
| Mar 2015 | - | $33.20 K(-10.8%) |
| Dec 2014 | $2600.00(-31.6%) | - |
| Dec 2014 | - | $37.20 K(-5.1%) |
| Sep 2014 | - | $39.20 K(-57.6%) |
| Jun 2014 | - | $92.50 K(-18.6%) |
| Mar 2014 | - | $113.60 K(-12.5%) |
| Dec 2013 | $3800.00(-30.9%) | - |
| Dec 2013 | - | $129.90 K(-25.5%) |
| Sep 2013 | - | $174.40 K(+459.0%) |
| Jun 2013 | - | $31.20 K(-3.7%) |
| Mar 2013 | - | $32.40 K(-27.7%) |
| Dec 2012 | $5500.00(-16.7%) | - |
| Dec 2012 | - | $44.80 K(-34.4%) |
| Sep 2012 | - | $68.30 K(-6.6%) |
| Jun 2012 | - | $73.10 K(-26.9%) |
| Mar 2012 | - | $100.00 K(+18.1%) |
| Dec 2011 | $6600.00(-8.3%) | - |
| Dec 2011 | - | $84.70 K(-12.0%) |
| Sep 2011 | - | $96.20 K(-33.8%) |
| Jun 2011 | - | $145.30 K(-30.8%) |
| Mar 2011 | - | $210.10 K(-19.6%) |
| Dec 2010 | $7200.00 | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $261.30 K(+452.4%) |
| Sep 2010 | - | $47.30 K(+11.8%) |
| Jun 2010 | - | $42.30 K(-50.4%) |
| Mar 2010 | - | $85.30 K(-39.0%) |
| Dec 2009 | $5.11 M(+1.6%) | - |
| Dec 2009 | - | $139.80 K(-23.1%) |
| Sep 2009 | - | $181.90 K(-13.6%) |
| Jun 2009 | - | $210.50 K(-24.2%) |
| Mar 2009 | - | $277.80 K(-54.0%) |
| Dec 2008 | $5.03 M(+7.5%) | - |
| Dec 2008 | - | $603.30 K(-55.1%) |
| Sep 2008 | - | $1.34 M(+366.1%) |
| Jun 2008 | - | $288.00 K(-12.5%) |
| Mar 2008 | - | $329.00 K(-33.9%) |
| Dec 2007 | $4.67 M(+1.3%) | - |
| Dec 2007 | - | $497.70 K(+10.2%) |
| Sep 2007 | - | $451.60 K(+13.7%) |
| Jun 2007 | - | $397.10 K(+152.9%) |
| Mar 2007 | - | $157.00 K(-60.5%) |
| Dec 2006 | $4.61 M(+59.5%) | - |
| Dec 2006 | - | $397.30 K(-64.0%) |
| Sep 2006 | - | $1.10 M(-36.2%) |
| Jun 2006 | - | $1.73 M(+311.7%) |
| Mar 2006 | - | $420.00 K(-28.7%) |
| Dec 2005 | $2.89 M(+103.9%) | - |
| Dec 2005 | - | $589.30 K(-50.1%) |
| Sep 2005 | - | $1.18 M(-32.8%) |
| Jun 2005 | - | $1.76 M(-9.8%) |
| Mar 2005 | - | $1.95 M(-9.0%) |
| Dec 2004 | $1.42 M(+138.6%) | - |
| Dec 2004 | - | $2.14 M(+224.0%) |
| Sep 2004 | - | $660.00 K(-26.8%) |
| Jun 2004 | - | $901.90 K(-1.9%) |
| Mar 2004 | - | $919.60 K(+77.7%) |
| Dec 2003 | $594.80 K(+10.3%) | - |
| Dec 2003 | - | $517.60 K(+41.0%) |
| Sep 2003 | - | $367.20 K(+1496.5%) |
| Jun 2003 | - | $23.00 K(-55.1%) |
| Mar 2003 | - | $51.20 K(+77.2%) |
| Dec 2002 | $539.50 K(+3.9%) | - |
| Dec 2002 | - | $28.90 K(-31.4%) |
| Sep 2002 | - | $42.10 K(-43.3%) |
| Jun 2002 | - | $74.20 K(+145.7%) |
| Mar 2002 | - | $30.20 K(-3.2%) |
| Dec 2001 | $519.30 K(-3.4%) | - |
| Dec 2001 | - | $31.20 K(+27.9%) |
| Sep 2001 | - | $24.40 K(-85.0%) |
| Jun 2001 | - | $162.20 K(-12.3%) |
| Mar 2001 | - | $185.00 K(-21.1%) |
| Dec 2000 | $537.80 K(+626.8%) | - |
| Dec 2000 | - | $234.40 K(+35.5%) |
| Sep 2000 | - | $173.00 K(-6.0%) |
| Jun 2000 | - | $184.00 K(+2.8%) |
| Mar 2000 | - | $179.00 K(-12.9%) |
| Dec 1999 | $74.00 K(-90.0%) | - |
| Dec 1999 | - | $205.60 K(-37.5%) |
| Dec 1998 | $740.50 K(-41.7%) | - |
| Dec 1998 | - | $329.20 K(-57.5%) |
| Dec 1997 | $1.27 M(+36.5%) | - |
| Dec 1997 | - | $774.50 K |
| Dec 1996 | $930.70 K | - |
FAQ
- What is ImmunoPrecise Antibodies annual total current assets?
- What is the all time high annual current assets for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual current assets year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total current assets?
- What is the all time high quarterly current assets for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly current assets year-on-year change?
What is ImmunoPrecise Antibodies annual total current assets?
The current annual current assets of IPA is $8.40 M
What is the all time high annual current assets for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total current assets is $39.80 M
What is ImmunoPrecise Antibodies annual current assets year-on-year change?
Over the past year, IPA annual total current assets has changed by -$3.89 M (-31.64%)
What is ImmunoPrecise Antibodies quarterly total current assets?
The current quarterly current assets of IPA is $8.99 M
What is the all time high quarterly current assets for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total current assets is $39.80 M
What is ImmunoPrecise Antibodies quarterly current assets year-on-year change?
Over the past year, IPA quarterly total current assets has changed by +$1.03 M (+12.99%)